Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
8.67
-1.09 (-11.17%)
Jul 13, 2026, 4:00 PM EDT - Market closed
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $78.12 million as of July 14, 2026. Its market cap has increased by 64.81% in one year.
Market Cap
78.12M
Enterprise Value
79.85M
1-Year Change
64.81%
Ranking
Category
Stock Price
$8.67
Market Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $78.12M, a decrease of -63.72%. That is a compound annual growth rate of -8.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 78.10M | -40.11% |
| Dec 31, 2025 | 130.40M | 70.01% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
| Oct 16, 2014 | 215.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 92.28M |
| Alps Group | 91.74M |
| Rein Therapeutics | 91.18M |
| Cardiff Oncology | 90.93M |
| LeonaBio | 90.18M |
| OKYO Pharma | 88.69M |
| NeurAxis | 88.42M |
| MAIA Biotechnology | 87.55M |